Evidence map›Paper›PMID 35583638›Full record

ArticleAdvances in experimental medicine and biology2022

Challenges in Nanomaterial Characterization - From Definition to Analysis.

José A M Catita

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

José A M CatitaFP-ENAS, Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal. jcatita@ufp.edu.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanomaterials have outstanding properties and have several applications, ranging from foods, cosmetics, pharmaceuticals to energy, construction, etc. As with all novel products, the benefits of nanomaterials use must be weighed against its health and environmental impact. They have different origins, natural, incidental, or engineered, they are widespread, and they need to be classified and characterized for various purposes, including nanotoxicology studies and risk assessment, workplaces and environment safety evaluation, consumer products evaluation, as well as manufacturing process control. To properly characterize nanomaterials, a consensual definition of nanomaterial is needed, and several analyses using the available characterization techniques must be performed. Various properties are relevant in the characterization process and many of them, namely size, are still a challenge that the research community is facing. The measurement of physical and chemical properties is very important in the case of nanomaterials. In view of this, in this chapter, available analytical techniques are reviewed based on nanomaterials classification, regulatory demands and toxicology assessment. Additionally, some of the current major challenges and gaps in nanomaterials characterization are identified and listed.

Indexed as

CosmeticsNanostructuresRisk AssessmentCosmeticsNanomaterial characterizationNanomaterial classificationNanomaterial properties

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.